BRVE (Braveheart Bio) Market Cap: $0.00 Mil (As of Aug. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BRVE Braveheart Bio Inc BRVE
8 GF Score
Price $31.93
View Full Analysis

What is Braveheart Bio Market Cap?

Braveheart Bio BRVE -2.72% 8 Market Cap is $0.00 Mil as of Aug. 09, 2026. GuruFocus rates BRVE with a GF Score™ of 8/100.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Braveheart Bio's share price for the quarter that ended in Dec. 2025 was $0. Braveheart Bio's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 12.41 Mil. Therefore, Braveheart Bio's market cap for the quarter that ended in Dec. 2025 was $0.00 Mil.

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Braveheart Bio's Enterprise Value for Today is $0.00 Mil.

Braveheart Bio  (NAS:BRVE) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Braveheart Bio Market Cap Related Terms

Braveheart Bio Market Cap Historical Data

* Premium members only.

The historical data trend for Braveheart Bio's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Braveheart Bio Market Cap Chart

Braveheart Bio Annual Data
Trend Dec25
Market Cap
0.00

Braveheart Bio Semi-Annual Data
Dec25
Market Cap 0.00

BRVE vs : Market Cap Comparison

For the Biotechnology subindustry, Braveheart Bio's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Braveheart Bio Market Cap vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Braveheart Bio's Market Cap distribution charts can be found below:

* The bar in red indicates where Braveheart Bio's Market Cap falls into.


BRVE
8GF Score
Braveheart Bio Inc BRVE
Market Cap is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Braveheart Bio Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Braveheart Bio's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as

Market Cap (A: Dec. 2025 )=Share Price (A: Dec. 2025 )*Shares Outstanding (EOP) (A: Dec. 2025 )
=$0*12.411
=$0.00

Braveheart Bio's Market Cap for the quarter that ended in Dec. 2025 is calculated as

Market Cap (Q: Dec. 2025 )=Share Price (Q: Dec. 2025 )*Shares Outstanding (EOP) (Q: Dec. 2025 )
=$0*12.411
=$0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of $0.00 Mil mean?
Braveheart Bio (BRVE) has a Market Cap of $0.00 Mil as of Aug. 09, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Braveheart Bio and its competitors.
Is Braveheart Bio's Market Cap too high?
Braveheart Bio's current Market Cap is $0.00 Mil. Overall, Braveheart Bio has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Braveheart Bio's Market Cap compare to ?
Braveheart Bio's Market Cap of $0.00 Mil can be compared against companies in the Biotechnology industry. The industry median Market Cap is 116.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 116.70, based on 1,423 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Braveheart Bio and its competitors. For the Biotechnology industry, the median Market Cap is 116.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Braveheart Bio's current Market Cap is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Braveheart Bio stock overvalued right now?
Braveheart Bio (BRVE) has a current Market Cap of $0.00 Mil. The current Market Cap is $0.00 Mil. Braveheart Bio's overall GF Score™ is 8/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Braveheart Bio (BRVE), the current Market Cap is $0.00 Mil as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Braveheart Bio Business Description

Comparable Companies
Address One Letterman Drive, Suite A4-300, Building A, San Francisco, CA, USA, 94129
Braveheart Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and other cardiovascular diseases. Its flagship product candidate, BHB-1893, is an oral small-molecule cardiac myosin inhibitor being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM).
8GF Score

Get the complete analysis for BRVE

Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$31.93
Price